BRIDGE Device for Treatment of Opioid Withdrawal

Stopped early · Not applicable · Has a placebo group

Conditions studied: Opioid Withdrawal, Pain, Craving

In brief

The purpose of this study is to prospectively evaluate the effectiveness of the NSS-2 BRIDGE device in reducing the signs and symptoms of acute opioid withdrawal when compared to placebo.

Key facts

Study ID

NCT04162145

Run by

BrightView LLC

People needed

12

Starts

2019-11-15

Expected to finish

2020-06-23

Last updated by the study team

2020-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants will be 18 years or older who speak English and meet criteria for opioid use disorder based on the Diagnostic and Statistical Manual of Mental Disorders-5.

Where it is running

• Brightview LLC — Cincinnati, Ohio, United States
• BrightView — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.